NTMir Announces Research Grants for Epidemiology and Household Water as Source of... ( CORAL GABLES Fla. Nov. 9 /- NTM I...)

NTMir Announces Research Grants for Epidemiology and Household Water as Source of Infection

Date:11/9/2007

CORAL GABLES, Fla., Nov. 9 /PRNewswire/ -- NTM Info & Research (NTMir), a not-for-profit organization that supports education and research for nontuberculous mycobacterial (NTM) lung disease announces the implementation of Rapid Information Pilot Studies (RIPS(TM)), an innovative program to provide guidance about pressing issues regarding NTM host vulnerability, sources of infection, and clinical and treatment issues. Small pilot studies will be conducted so that information will be available within 12 months of grant approval, and will justify large-scale, multi-centered studies to explore the issues identified by the RIPS(TM) program.

NTMir is pleased to announce that it has awarded a RIPS(TM) grant to Dr. Joseph Falkinham, III, at Virginia Tech in Blacksburg, Virginia to study household water systems as a source of pulmonary NTM infection. This project will be initiated and completed during 2008, providing important information regarding the risk factors associated with household water and NTM lung infection. This study will be the first in a series designed to better understand both environmental and host factors of human infection with NTM.

NTMir is pleased to announce that it has awarded a RIPS(TM) grant jointly to National Institute of Allergy and Infectious Disease (NIAID) and Kaiser Permanente of Southern California (Kaiser), a private healthcare provider, to study the prevalence, prevalence trends, and co-morbidities of pulmonary NTM disease. This study represents an opportunity to evaluate the prevalence of NTM within a closed healthcare system and a unique partnership between a federal government agency (NIAID), a private healthcare system (Kaiser), and a disease-centered not-for-profit organization (NTMir).

SOURCE NTM Info & Research
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1
Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:

NTMir Announces Research Grants for Epidemiology and Household Water as Source of...( CORAL GABLES Fla. Nov. 9 /- NTM I...),Health